Quick Dispatch:
Your tirzepatide vs dulaglutide Tirzepatide tied to greater weight loss, glucose control vs. escalated dulaglutide orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide vs dulaglutide Tirzepatide tied to greater weight loss, glucose control vs. escalated dulaglutide ships.
Need Help?
Questions about tirzepatide vs dulaglutide Tirzepatide tied to greater weight loss, glucose control vs. escalated dulaglutide, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide vs dulaglutide Tirzepatide tied to greater weight loss, glucose control vs. escalated dulaglutide in your area.
Tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURPASS-CVOT) | NEJM
28.05
Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS-SWITCH
20.30
💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that tirzepatide was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What
27.10
Tirzepatide vs. Dulaglutide: Cardiovascular Outcomes in Type 2 Diabetes
24.14
Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide: A Randomized Clinical Trial: Annals of Internal Medicine: Vol 178, No 5
26.81
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes @NEJM Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to a composite of
28.31
Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT
22.69
